Volume 22 Issue 12
Dec.  2024
Turn off MathJax
Article Contents
ZHENG Qian, YU Caiyao, LI Haoyun, FENG Zhanhui. Systemic lupus erythematosus and myasthenia gravis: a bidirectional Mendelian randomization study[J]. Chinese Journal of General Practice, 2024, 22(12): 2020-2024. doi: 10.16766/j.cnki.issn.1674-4152.003788
Citation: ZHENG Qian, YU Caiyao, LI Haoyun, FENG Zhanhui. Systemic lupus erythematosus and myasthenia gravis: a bidirectional Mendelian randomization study[J]. Chinese Journal of General Practice, 2024, 22(12): 2020-2024. doi: 10.16766/j.cnki.issn.1674-4152.003788

Systemic lupus erythematosus and myasthenia gravis: a bidirectional Mendelian randomization study

doi: 10.16766/j.cnki.issn.1674-4152.003788
Funds:

 82360266

  • Received Date: 2024-08-17
    Available Online: 2025-01-20
  •   Objective  Studies have shown that systemic lupus erythematosus (SLE) and Myasthenia gravis (MG) may have concurrent onset clinically. This study aims to explore the potential causal relationship between SLE and MG using a bidirectional Mendelian randomization study to provide a basis for clinical prevention and treatment.  Methods  Genetic data closely related to SLE and MG were extracted from the summary database of genome-wide association studies (GWAS) as instrumental variables, and the extracted data were all from European samples. MR analysis was conducted using IVW, MR-Egger regression, and WME. The causal relationship between SLE and MG was evaluated by the OR value and 95% CI. The MR-Egger intercept method was used to detect horizontal pleiotropy, and the leave-one-out method was used for sensitivity analysis.  Results  SLE was associated with an increased risk of MG (OR=1.698, 95% CI: 1.329-2.171, P<0.001); similarly, MG was associated with an increased risk of SLE (OR=1.527, 95% CI: 1.248-1.869, P<0.001). There was no heterogeneity in the two-way results and no horizontal pleiotropy. The sensitivity analysis results of the leave-one-out method were stable.  Conclusion  There is a bidirectional causal relationship between SLE and MG. SLE patients will increase the risk of MG onset, and MG will also increase the risk of SLE onset.

     

  • loading
  • [1]
    王玲玲, 扶琼, 吴春梅. 外周血浆细胞比值在系统性红斑狼疮病情监测中的临床价值[J]. 临床内科杂志, 2023, 40(8): 535-539. doi: 10.3969/j.issn.1001-9057.2023.08.009

    WANG L L, FU Q, WU C M. Clinical value of peripheral plasma cell ratio in monitoring the condition of systemic lupus erythematosus[J]. Journal of Clinical Internal Medicine, 2023, 40(8): 535-539. doi: 10.3969/j.issn.1001-9057.2023.08.009
    [2]
    GARCÍA ESTÉVEZ D A, PARDO FERNÁNDEZ J. Myasthenia gravis. Update on diagnosis and therapy[J]. Med Clin (Barc), 2023, 161(3): 119-127. doi: 10.1016/j.medcli.2023.04.006
    [3]
    王美萍, 张哲宇, 张圣, 等. 免疫抑制剂治疗重症肌无力伴胸腺异常患者的临床观察研究[J]. 中华全科医学, 2020, 18(12): 2002-2005. doi: 10.16766/j.cnki.issn.1674-4152.001673

    WANG M P, ZHANG Z Y, ZHANG S, et al. Clinical observation of immunosuppressive therapy for myasthenia gravis with thymus abnormalities[J]. Chinese Journal of General Practice, 2020, 18(12): 2002-2005. doi: 10.16766/j.cnki.issn.1674-4152.001673
    [4]
    ALI M, RIAD M, ADHIKARI P, et al. Association between myasthenia gravis and systemic lupus erythematosus as a comorbid state[J]. Cureus, 2021, 13(4): e14719. DOI: 10.7759/cureus.14719.
    [5]
    ELDAABOSSI S, ALRASHDAN M, ALJANOBI G, et al. A rare association: obesity hypoventilation syndrome with myasthenia gravis and systemic lupus erythematosus, case report[J]. Respir Med Case Rep, 2023, 44(5): 101848. DOI: 10.1016/j.rmcr.2023.101848.
    [6]
    PATKI A Y, DURGA P, GANGISHETTY A, et al. Myasthenia gravis: an unanticipated cause of failure to wean in a postpartum patient with preexisting systemic lupus erythematosus[J]. Indian J Crit Care Med, 2022, 26(6): 731-732. doi: 10.5005/jp-journals-10071-24228
    [7]
    YERRAM K, BAISYA R, DEVARASETTI P K. Postpartum myasthenic crisis in a patient with SLE: a case report and literature review[J]. Mediterr J Rheumatol, 2022, 33(4): 449-452. doi: 10.31138/mjr.33.4.449
    [8]
    KLIMI E, KATAXAKI E. Systemic lupus erythematosus and myasthenia gravis in a male patient: an HLA case investigated[J]. Mediterr J Rheumatol, 2021, 32(3): 285-286. doi: 10.31138/mjr.32.3.285
    [9]
    JIMÉNEZ-ALONSO J, NAVARRETE-NAVARRETE N, JIMÉNEZ-JÁIMEZ E, et al. Myasthenia gravis and systemic lupus erythematosus: presentation of 5 cases and PubMed review[J]. Neurologia (Engl Ed), 2021, 36(7): 556-557.
    [10]
    BROADBENT J R, FOLEY C N, GRANT A J, et al. Mendelian Randomization v0.5.0: updates to an R package for performing Mendelian randomization analyses using summarized data[J]. Wellcome Open Res, 2020, 5(12): 252. DOI: 10.12688/wellcomeopenres.16374.2.
    [11]
    SAKAUE S, KANAI M, TANIGAWA Y, et al. A cross-population atlas of genetic associations for 220 human phenotypes[J]. Nat Genet, 2021, 53(10): 1415-1424. doi: 10.1038/s41588-021-00931-x
    [12]
    CHIA R, SAEZ-ATIENZAR S, MURPHY N, et al. Identification of genetic risk loci and prioritization of genes and pathways for myasthenia gravis: a genome-wide association study[J]. Proc Natl Acad Sci USA, 2022, 119(5): e2108672119. DOI: 10.1073/pnas.2108672119.
    [13]
    CHO Y, HAYCOCK P C, SANDERSON E, et al. Exploiting horizontal pleiotropy to search for causal pathways within a Mendelian randomization framework[J]. Nat Commun, 2020, 11(1): 1010. DOI: 10.1038/s41467-020-14452-4.
    [14]
    MANUJA N, KUMAR S, ACHARYA S, et al. Simultaneous myasthenic crisis with thyrotoxic crisis in an adult male: an autoimmune overlap[J]. Cureus, 2023, 15(8): e44366. DOI: 10.7759/cureus.44366.
    [15]
    NAGARAJAN M, MAASILA A T, DHANAPRIYA J, et al. Systemic lupus erythematosus and myasthenia gravis: a rare association[J]. Indian J Nephrol, 2019, 29(1): 62-64. doi: 10.4103/ijn.IJN_12_18
    [16]
    GARCÍA-ALFONSO C, BERNAL-MACÍAS S, GARCÍA-PARDO Y, et al. Coexistence of systemic lupus erythematosus and myasthenia gravis: an unusual case of polyautoimmunity[J]. Reumatol Clin (Engl Ed), 2020, 16(6): 502-505. doi: 10.1016/j.reuma.2018.08.013
    [17]
    ZHU Y, WANG B Q, HAO Y H, et al. Clinical features of myasthenia gravis with neurological and systemic autoimmune diseases[J]. Front Immunol, 2023, 14(9): 1223322. DOI: 10.3389/fimmu.2023.1223322.
    [18]
    PAN Z J, ZHU T, LIU Y J, et al. Role of the CXCL13/CXCR5 axis in autoimmune diseases[J]. Front Immunol, 2022, 13(5): 850998. DOI: 10.3389/fimmu.2022.850998.
    [19]
    LOTFI N, THOME R, REZAEI N, et al. Roles of GM-CSF in the pathogenesis of autoimmune diseases: an update[J]. Front Immunol, 2019, 10(6): 1265. DOI: 10.3389/fimmu.2019.01265.
    [20]
    LIU X X, MA Q, QIU L, et al. Quantitative features and clinical significance of two subpopulations of AChR-specific CD4+ T cells in patients with myasthenia gravis[J]. Clin Immunol, 2020, 216(7): 108462. DOI: 10.1016/j.clim.2020.108462.
    [21]
    WANG N, YUAN J, KARIM M R, et al. Effects of mitophagy on regulatory T Cell function in patients with myasthenia gravis[J]. Front Neurol, 2020, 11(4): 238. DOI: 10.3389/fneur.2020.00238.
    [22]
    ELDAABOSSI S, ALRASHDAN M, ALJANOBI G, et al. A rare association: Obesity hypoventilation syndrome with myasthenia gravis and systemic lupus erythematosus, case report[J]. Respir Med Case Rep, 2023, 44(5): 101848. DOI: 10.1016/j.rmcr.2023.101848.
    [23]
    ZHONG H H, ZHAO C B, LUO S S. HLA in myasthenia gravis: from superficial correlation to underlying mechanism[J]. Autoimmun Rev, 2019, 18(9): 102349. DOI: 10.1016/j.autrev.2019.102349.
    [24]
    VNLV B, TVRSEN V, JABALAMELI N, et al. Immunogenetics of lupus erythematosus[J]. Adv Exp Med Biol, 2022, 1367(3): 213-257.
  • 加载中

Catalog

    通讯作者: 陈斌, bchen63@163.com
    • 1. 

      沈阳化工大学材料科学与工程学院 沈阳 110142

    1. 本站搜索
    2. 百度学术搜索
    3. 万方数据库搜索
    4. CNKI搜索

    Figures(4)  / Tables(1)

    Article Metrics

    Article views (15) PDF downloads(8) Cited by()
    Proportional views
    Related

    /

    DownLoad:  Full-Size Img  PowerPoint
    Return
    Return